C07C 311/21
Having the nitrogen atom of at least one of the sulfonamide groups
Official title: having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
C07C311/21 (Having the nitrogen atom of at least one of the sulfonamide groups) appears on 639 US grants and 670 published applications in this corpus.
Search patents in C07C- Granted patents
- 639
- Published applications
- 670
- Assignees
- 388
- Inventors
- 2,380
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 9 | 0 |
| 1979 | 2 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 4 | 0 |
| 1992 | 6 | 0 |
| 1993 | 5 | 0 |
| 1994 | 9 | 0 |
| 1995 | 9 | 0 |
| 1996 | 8 | 0 |
| 1997 | 7 | 0 |
| 1998 | 18 | 0 |
| 1999 | 24 | 0 |
| 2000 | 18 | 0 |
| 2001 | 26 | 6 |
| 2002 | 32 | 23 |
| 2003 | 28 | 51 |
| 2004 | 29 | 46 |
| 2005 | 14 | 32 |
| 2006 | 23 | 30 |
| 2007 | 23 | 33 |
| 2008 | 26 | 32 |
| 2009 | 13 | 32 |
| 2010 | 26 | 39 |
| 2011 | 22 | 29 |
| 2012 | 26 | 26 |
| 2013 | 15 | 18 |
| 2014 | 18 | 31 |
| 2015 | 29 | 33 |
| 2016 | 21 | 17 |
| 2017 | 19 | 24 |
| 2018 | 15 | 20 |
| 2019 | 27 | 22 |
| 2020 | 12 | 26 |
| 2021 | 15 | 18 |
| 2022 | 11 | 20 |
| 2023 | 12 | 10 |
| 2024 | 9 | 21 |
| 2025 | 9 | 17 |
| 2026 | 8 | 14 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compound, polymerizable composition, polymer, and polymerized film22 Sep 2026US 12,741,936 B2FUJIFILM Corporation
- Sulfone compounds and pharmaceutical compositions thereof, and their therapeutic applications11 Aug 2026US 12,703,679 B2Cura Therapeutics, LLC
- Phenyl-sulfamoyl-benzoic acid derivatives as ERAP1-modulators28 Jul 2026US 12,692,223 B2Grey Wolf Therapeutics Limited
- Methods of treating cancer21 Apr 2026US 12,606,521 B2Institute For Cancer Research
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives21 Apr 2026US 12,606,522 B2OrsoBio, Inc.
- Methods of treating cancer24 Sep 2026US 2026/0285807 A1Institute for Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center
- Photoswitchable compounds and affinity ligands, and their use for the optical control of affinity matrices10 Sep 2026US 2026/0265179 A1AFC Innovations GmbH
- Methods and compositions for prevention of anaphylaxis20 Aug 2026US 2026/0242369 A1Baylor College of Medicine
- Usp2 inhibitors and methods of using the same for the treatment of diseases20 Aug 2026US 2026/0242394 A1Beth Israel Deaconess Medical Center, Inc.
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives16 Jul 2026US 2026/0200844 A1OrsoBio, Inc.
Most cited
By later US patents
- Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method125US 5,760,246 A1998
- Catecholamine surrogates useful as .beta..sub.3 agonists122US 5,776,983 ABristol-Myers Squibb Company · 1998
- Aryl and heteroaryl compounds, compositions and methods of use99US 7,501,538 B2TransTech Pharma, Inc. · 2009
- Aryl and heteroaryl compounds, compositions, and methods of use94US 7,459,472 B2TransTech Pharma, Inc. · 2008
- IL-8 receptor antagonists92US 5,886,044 ASmithKline Beecham Corporation · 1999